Contract

Ravulizumab IV Infusion

  • BELFAST HEALTH AND SOCIAL CARE TRUST

F03: Contract award notice

Notice identifier: 2024/S 000-013110

Procurement identifier (OCID): ocds-h6vhtk-045463

Published 23 April 2024, 11:35am



Section one: Contracting authority

one.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

Contact

Norma Moore

Email

FinanceProcurement@belfasttrust.hscni.net

Country

United Kingdom

Region code

UKN06 - Belfast

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://belfasttrust.hscni.net

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Ravulizumab IV Infusion

Reference number

DACPM2023-109

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Procurement of Ravulizumab IV Infusion

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1,194,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKN - Northern Ireland
Main site or place of performance

Belfast Health & Social Care Trust - Pharmacy

two.2.4) Description of the procurement

Procurement of Ravulizumab IV Infusion

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • protection of exclusive rights, including intellectual property rights

Explanation:

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

DACPM2023-109

Title

Ravulizumab IV Infusion

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

18 April 2024

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Alexion Pharma UK Ltd

3 Furzeground Way Stockley Park

Uxbridge

UB11 1EZ

Country

United Kingdom

NUTS code
  • UKJ - South East (England)
Companies House

05970106

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £119,400

Total value of the contract/lot: £1,194,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Belfast Health and Social Care Trust

Knockbracken Healthcare Park

Belfast

BT8 8BH

Email

FinanceProcurement@belfasttrust.hscni.net

Country

United Kingdom